表型风险评分而非遗传风险评分有助于在电子健康记录中识别系统性红斑狼疮个体
利用去标识电子健康记录数据库与DNA生物库,纳入789例SLE病例和2261例对照,构建基于账单编码的SLE表型风险评分(PheRS)和基于58个SLE风险单核苷酸多态性的遗传风险评分(GRS)。SLE病例的PheRS和GRS均显著高于对照,仅用PheRS预测SLE的AUC为0.87,加入GRS后AUC为0.89,差异极小;GRS在黑人SLE个体中效用有限。
要点
- SLE病例PheRS均值7.7±8.0,显著高于对照的0.8±2.0(P<0.001)。
- 仅用PheRS预测SLE的AUC为0.87,加入GRS后AUC为0.89,差异极小。
- GRS在黑人SLE个体中效用有限,需更多工作理解不同人群的SLE遗传风险。
核心结论
- 研究开发了SLE表型风险评分(PheRS),可识别已确诊和未确诊的SLE个体。
- 使用已知风险SNP的SLE遗传风险评分(GRS)未能在PheRS基础上增加价值,且在黑人SLE个体中效用有限。
- 需要更多工作来理解不同人群中SLE的遗传风险。
研究设计与样本
- 使用去标识电子健康记录数据库及关联DNA生物库,识别789例SLE病例和2261例对照,均有MEGAEX基因分型数据。
- SLE的PheRS基于捕获美国风湿病学会SLE分类标准的账单编码开发。
- GRS基于58个SLE风险单核苷酸多态性(SNP)开发。
主要发现
- SLE病例PheRS均值±标准差为7.7±8.0,对照为0.8±2.0,病例显著更高(P<0.001)。
- SLE病例GRS均值±标准差为12.2±2.3,对照为11.0±2.0,病例显著更高(P<0.001)。
- 黑人SLE个体PheRS均值±标准差为10.0±10.1,高于白人SLE个体的7.1±7.2(P=0.002)。
- 黑人SLE个体GRS均值±标准差为9.0±1.4,低于白人SLE个体的12.3±1.7(P<0.001)。
- 仅用PheRS预测SLE的AUC为0.87,加入GRS后AUC为0.89,差异极小。
局限性
- 原文结论指出需要更多工作来理解不同人群中SLE的遗传风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Systemic lupus erythematosus (SLE) poses diagnostic challenges. We undertook this study to evaluate the utility of a phenotype risk score (PheRS) and a genetic risk score (GRS) to identify SLE individuals in a real-world setting. METHODS: Using a de-identified electronic health record (EHR) database with an associated DNA biobank, we identified 789 SLE cases and 2,261 controls with available MEGAEX genotyping. A PheRS for SLE was developed using billing codes that captured American College of Rheumatology SLE criteria. We developed a GRS with 58 SLE risk single-nucleotide polymorphisms (SNPs). RESULTS: SLE cases had a significantly higher PheRS (mean ± SD 7.7 ± 8.0 versus 0.8 ± 2.0 in controls; P < 0.001) and GRS (mean ± SD 12.2 ± 2.3 versus 11.0 ± 2.0 in controls; P < 0.001). Black individuals with SLE had a higher PheRS compared to White individuals (mean ± SD 10.0 ± 10.1 versus 7.1 ± 7.2, respectively; P = 0.002) but a lower GRS (mean ± SD 9.0 ± 1.4 versus 12.3 ± 1.7, respectively; P < 0.001). Models predicting SLE that used only the PheRS had an area under the curve (AUC) of 0.87. Adding the GRS to the PheRS resulted in a minimal difference with an AUC of 0.89. On chart review, controls with the highest PheRS and GRS had undiagnosed SLE. CONCLUSION: We developed a SLE PheRS to identify established and undiagnosed SLE individuals. A SLE GRS using known risk SNPs did not add value beyond the PheRS and was of limited utility in Black individuals with SLE. More work is needed to understand the genetic risks of SLE in diverse populations.
引用
- Barnado A, Wheless L, Camai A, et al. Phenotype Risk Score but Not Genetic Risk Score Aids in Identifying Individuals With Systemic Lupus Erythematosus in the Electronic Health Record. Arthritis Rheumatol. 2023. PMID: 37096581. doi:10.1002/art.42544
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。